Skip to main content
. 2023 Jan 12;22:10. doi: 10.1186/s12943-022-01708-4

Fig. 8.

Fig. 8

Illustration of cRGD-installed reduction-responsive crosslinked nanotherapeutics from star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) for enhanced DOX delivery to B16F10 melanoma bearing mice in vivo, reproduced with permission from [277], copyright 2019, American Chemical Society